Steno Diabetes Centre, Gentofte, Denmark.
Nephrol Dial Transplant. 2011 Oct;26(10):3242-9. doi: 10.1093/ndt/gfr009. Epub 2011 Mar 3.
Elevated plasma N-terminal (NT)-proBNP levels and coronary calcium score (CCS) not only predicts myocardial ischaemia and coronary artery stenosis but also adverse cardiovascular events and mortality in type 2 diabetic patients with an increased urinary albumin excretion rate (UAER), whereas low levels are associated with low frequency of coronary artery disease (CAD) and good prognosis. The underlying causes of poor prognosis in patients with elevated NT-proBNP are not known; thus, we investigated the role of putative asymptomatic CAD in type 2 diabetic patients with UAER >30 mg/24 h and elevated P-NT-proBNP and/or CCS.
We identified 200 type 2 diabetic patients without known CAD and with normal creatinine levels. Patients with P-NT-proBNP >45.2 ng/L (the median P-NT-proBNP value in this cohort and in accordance with our previous findings) and/or CCS ≥ 400 were stratified as high-risk patients for CAD (n = 133) and all other patients as low-risk patients (n = 67). High-risk patients were examined by myocardial perfusion imaging (MPI; n = 109) and/or computer tomography angiography (n = 20) and/or coronary angiography (CAG; n = 86).
All patients received intensive mulitifactorial intervention. In 70 of 133 (53%) high-risk patients, significant CAD was demonstrated by MPI and/or CAG, corresponding to 35% (70/200) of the total cohort. Among high-risk patients, CCS but not P-NT-proBNP was paralleled by increased prevalence of significant CAD and in the 86 patients where CAG was performed, a CCS <100 had a negative predictive value for coronary artery stenosis of 94% (P = 0.04).
Our study revealed that >50% of asymptomatic type 2 diabetic patients with UAER >30 mg/24 h had significant CAD based on risk stratification with P-NT-proBNP and CCS. This provides some explanation to the previously reported poor prognosis in these asymptomatic patients. Optimized cardio protective treatment in these patients is warranted.
在伴有尿白蛋白排泄率(UAER)升高的 2 型糖尿病患者中,升高的血浆 N 端(NT)-脑利钠肽前体(proBNP)水平和冠状动脉钙评分(CCS)不仅预测心肌缺血和冠状动脉狭窄,而且预测心血管不良事件和死亡率,而低水平与冠状动脉疾病(CAD)的低发生率和良好预后相关。升高的 NT-proBNP 患者预后不良的潜在原因尚不清楚;因此,我们研究了在伴有 UAER>30mg/24h 和升高的 P-NT-proBNP 和/或 CCS 的 2 型糖尿病患者中,推测的无症状 CAD 的作用。
我们确定了 200 名无已知 CAD 且肌酐水平正常的 2 型糖尿病患者。P-NT-proBNP>45.2ng/L(本队列和我们之前研究中的中位数 P-NT-proBNP 值)和/或 CCS≥400 的患者被分为 CAD 高危患者(n=133)和所有其他患者为低危患者(n=67)。高危患者接受心肌灌注成像(MPI;n=109)和/或计算机断层血管造影(n=20)和/或冠状动脉造影(CAG;n=86)检查。
所有患者均接受强化多因素干预。在 133 名高危患者中,有 70 名(53%)通过 MPI 和/或 CAG 证实存在显著 CAD,占总队列的 35%(70/200)。在高危患者中,CCS 而不是 P-NT-proBNP 与显著 CAD 的患病率增加相关,在进行 CAG 的 86 名患者中,CCS<100 对冠状动脉狭窄的阴性预测值为 94%(P=0.04)。
我们的研究表明,在伴有 UAER>30mg/24h 的无症状 2 型糖尿病患者中,>50%的患者基于 P-NT-proBNP 和 CCS 进行危险分层,存在显著 CAD。这为这些无症状患者先前报道的不良预后提供了一些解释。这些患者需要优化心脏保护治疗。